MC Services is an international Corporate Communications and Investor Relations firm providing Life Sciences companies high-level consultancy, targeted services and support throughout Europe and beyond
Our Services
Corporate Communications
Designing, implementing and effectively operating international Corporate Communications programs is part of our core expertise.
Investor Relations
Our trained senior Investor Relations specialists provide a unique opportunity to have immediate access to the necessary tools, skills and networks you need in Europe, the UK and the US.
Roadshows & Transactions
Product & Science PR
Right from its scientific beginnings, and all the way through regulatory approval and market launch we support the strategic positioning and marketing of your product – and the science behind it – to the relevant stakeholders.
SELECTED CLIENTS – PAST AND PRESENT
Client News
InflaRx to Present Late-Breaking Pre-clinical Data on Izicopan at Kidney Week 2026
Fierce Biotech Names ReproNovo A “Fierce 15” Company Of 2026
iOmx Therapeutics Appoints Rüdiger Wolff as Chief Financial Officer
MC Services is media partner for BIO-Europe 2026
MC Services is proud to once again support BIO-Europe as official media partner. Taking place from November 9–11, 2026, in Cologne, Germany, BIO-Europe is the global strategic biopharma platform where senior industry leaders connect, align on priorities, and advance partnerships.
The 2026 edition will bring together more than 5,800 participants from over 3,200 companies across more than 60 countries, including biotech and pharma executives, investors and strategic partners. While partnering remains central, the program will also address broader industry priorities, from investment and dealmaking to clinical, regulatory and manufacturing strategy.
For more information on the program, timing and additional activities, please visit the event’s website.